Small and medium sized drug companies face triplicate business difficulties.

Under the uncertain circumstances of impending medical and pharmacy separation program the clinics and pharmacies cautiously controlled their professional drug purchase from the drug companies. As a result, especially a small and medium sized drug company faced a triplicate management difficulty. Their sales dropped remarkably, the credit collection from their major customers got delayed and th...